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Abstract 22 
Purposes: Incomplete tendon healing impairs the outcome of tendon ruptures and tendinopathies. 23 
Human Adipose-derived Stem Cells (hASCs) are promising for tissue engineering applications. 24 
Extracorporeal Shock Waves (ESW) are a leading choice for the treatment of several 25 
tendinopathies. In this study we investigated the effects of ESW treatment and tenogenic medium 26 
on the differentiation of hASCs into tenoblast-like cells. Materials and Methods: hASCs were 27 
treated with ESW generated by a piezoelectric device and tenogenic medium. Quantitative real-time 28 
PCR was used to check mRNA expression levels of tenogenic transcription factors, extracellular 29 
matrix proteins, and integrins. Western blot and immunofluorescence were used to detect collagen 1 30 
and fibronectin. Collagen fibers were evaluated by Masson staining. Calcium deposition was 31 
assessed by Alizarin Red staining. Results: The combined treatment improved the expression of the 32 
tendon transcription factors scleraxis and eyes absent 2, and of the extracellular matrix proteins 33 
fibronectin, collagen I, and tenomodulin. Cells acquired elongated and spindle shaped fibroblastic 34 
morphology; Masson staining revealed the appearance of collagen fibers. Finally, the combined 35 
treatment induced the expression of alpha 2, alpha 6 and beta 1 integrin subunits, suggesting a 36 
possible role in mediating ESW effects. Conclusions: ESW in combination with tenogenic medium 37 
improved the differentiation of hASCs towards tenoblast-like cells, providing the basis for ESW 38 
and hASCs to be used in tendon tissue engineering. 39 
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Introduction 47 
Tendon injuries and diseases are very common. Unfortunately, due to low cellularity and 48 
vascularization, tendon healing is often incomplete (1), and, to date, surgical treatments remain 49 
unsatisfactory (2). To overcome these limitations, cell therapy-based tissue engineering has now 50 
emerged as a potential alternative approach in the treatment of tendon diseases. Adult mesenchymal 51 
stem cells (MSCs) are multipotent lineages capable of differentiating into specialized tissues such 52 
as bone, cartilage, tendon, and ligaments; and for this reason, they have been proposed for tissue 53 
engineering to enhance tendon healing (3). MSCs can be extracted from bone marrow; but other 54 
sources have also been identified. Among these, adipose tissue represents an abundant source of 55 
MSCs with potential regenerative properties (4). Human Adipose-derived Stem Cells (hASCs) may 56 
therefore be considered as a powerful tool for treating tendinopathies (5), and very recently it has 57 
been demonstrated that a tenomodulin positive subpopulation of ASC is a promising source of 58 
tendon progenitor cells (6). Moreover, tenocytes respond to mechanical loading by modulating the 59 
extracellular environment through the formation and degradation of matrix proteins via a process 60 
termed mechanotransduction (7). Extracorporeal Shock Waves (ESW) are transient short-term 61 
acoustic pulses with high peak pressure and a very short rise time to peak pressure of the order of 62 
magnitude of nanoseconds and short pulse duration. ESW technology has been used in clinical 63 
practice since the 1980s, when it was first employed to break up kidney stones (8). More recently, 64 
shockwave therapy has emerged as a leading choice for the treatment of several orthopedic diseases 65 
(9) and different disorders such as proximal plantar fasciopathy, lateral elbow tendinopathy, calcific 66 
tendinopathy of the shoulder and patellar tendinopathy are tendon diseases where ESW treatment is 67 
being used successfully (10). 68 
Based on these observations, the aim of the present study was to investigate the effects of ESW 
69 
treatment on the differentiation of hASCs into tenoblast-like cells. 
70 
71 
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Materials and methods 
72 
Isolation, characterization and tenogenic differentiation of hASCs 
73 
hASCs were isolated from the waste subcutaneous-adipose tissue of 5 healthy female donors [range 74 
30–50 years, body mass index (BMI) <30 without any pathological obesity], undergoing elective 75 
liposuction, after written consent and Institutional Review Board authorization. Primary cultures 76 
were established following the procedure of Zuc et al 2001 (4). Briefly, after digestion of raw 77 
lipoaspirates (50–100ml) with 0.075% type I collagenase (Sigma–Aldrich, Saint Louis, MO, USA) 78 
for 30 min, hASCs were separated by centrifugation (2100 x g for 10 min), filtered and plated in 79 
basal medium, consisting of Dulbecco’s modified Eagle’s Medium (DMEM/F12) (Lonza; 80 
Switzerland) plus 10% fetal bovine serum (FBS) and with the addition of 50 U/mL penicillin and 81 
50 μg/mL streptomycin (all from GIBCO, Invitrogen Corp., Grand Island, NY, USA).  82 
hASCs at passage 4 were investigated by flow cytometry analysis for the expression of surface 83 
antigens. In details, cells were detached by 0.5% trypsin/0.2% EDTA (Sigma–Aldrich, Saint Louis, 84 
MO, USA); thereafter, the cells were washed with cold PBS (Phosphate Buffer Saline) (Sigma–85 
Aldrich, Saint Louis, MO, USA) and then resuspended in cold PBS plus 0.1% BSA (Bovine Serum 86 
Albumin) (Sigma–Aldrich, Saint Louis, MO, USA). The cells were incubated for 30 minutes in ice, 87 
using the following phycoerythrin (PE) or fluorescein isothiocyanate (FITC)-conjugated antibodies: 88 
mouse anti-human CD13, CD14 and CD34 (BD Biosciences, Franklin Lakes, NJ, USA); mouse 89 
anti-human CD45, CD90, CD105 and CD44 (Immunotech, Marseille, France). At the end of the 90 
incubation, two washings with cold PBS plus 0.1% of BSA were performed. Ten thousand events 91 
were acquired for each surface marker on flow cytometer (EPICS XL, Coulter Corp., Hialeah, FL, 92 
USA).  93 
To induce tendon cell differentiation, hASCs were cultured in tenogenic medium consisting of basal 94 
medium supplemented with 50ng/ml human Insulin-like Growth Factor-I (IGF-1) and 10ng/ml 95 
human Transforming Growth Factor beta 1 (TGF- 1) (11). hASCs cultured in basal medium were 96 
used as controls. 97 
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Primary cultures of human tenocytes: isolation and expansion 98 
Discarded fragments of semitendinosus tendons were collected from 2 healthy young donors (mean 99 
age = 23 ± 7 y) who underwent arthroscopic anterior cruciate ligament reconstruction with 100 
autologous hamstrings at our hospital. All patients gave written consent to the procedure and all 101 
procedures were carried out with institutional review board approval. Tenocytes were isolated 102 
following the procedure by Kraus et al. (12) with minor modifications. Tendon tissues were minced 103 
and enzymatically digested with 0.25% trypsin in DMEM/F12 overnight at 4°C. Subsequently,  thy 104 
were treated with 0.3% type I collagenase in DMEM/F12 with continuous agitation for 1h at 37°C. 105 
The isolated nucleated cells were then cultured in basal medium consisting of DMEM/F12 plus 106 
10% FBS, with 50 U/mL penicillin and 50 μg/mL streptomycin. Cell cultures were maintained at 107 
37°C in a humidified atmosphere with 5% CO2; the culture medium was changed every 3 days. 108 
When cells reached 80–90% confluence, they were detached by incubation with 0.5% trypsin/0.2% 109 
EDTA (Sigma–Aldrich, Saint Louis, MO, USA) and then expanded at a density of 110 
5 × 10
3
 cells/cm
2
. RNA and proteins were extracted from tenocytes at passages 2 to 4, to be used as 111 
positive controls in gene expression, western blots and immunofluorescence experiments. 112 
ESW treatment 113 
The shockwave generator utilized for hASC treatments is a piezoelectric device (Piezoson 100; 114 
Richard Wolf, Knittlingen, Germany), especially designed for clinical use in orthopaedics and 115 
traumatology. The experimental set-up has been reported previously (13). Briefly, 1 ml aliquots of 116 
hASC cell suspension adjusted to 1×10
6
 cell/ml were placed in 20mm polypropylene tubes (Nunc, 117 
Wiesbaden, Germany), which were then completely filled with culture medium. Subsequently, cells 118 
were gently pelleted by centrifugation at 250 x g in order to minimize motion during shockwave 119 
treatment. Each cell-containing tube was placed in vertical alignment with the focal area and was 120 
adjusted so that the central point of the focal area corresponded to the centre of the tube bottom. 121 
The shockwave unit was kept in contact with the cell containing tube by means of a water-filled 122 
cushion. Common ultrasound gel was used as a contact medium between cushion and tube. hASC 123 
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cells were treated as follows: 1) control cells maintained in DMEM/F12 plus FBS 10% (Basal); 2) 124 
ESW-treated cells (Energy Flux Density, EFD=0.32mJ/mm
2
; peak positive pressure 90 MPa) 125 
receiving a number of 1000 shots (frequency = 4 shocks/s) and maintained in DMEM/F12 plus FBS 126 
10% (ESW); 3) cells maintained in tenogenic medium (TENO); 4) ESW-treated cells 127 
(EFD=0.32mJ/mm
2
; 1000 shots) maintained in tenogenic medium (TENO ESW). 128 
Cell viability  129 
After treatments as above, cells were seeded at 3×10
3 
cells/well in 96-well plates (Corning, New 130 
York, NY, USA). At 1, 3, 5, 7 and 9 days, cell viability was assessed using the Cell Proliferation 131 
Reagent WST-1 (Roche Applied Science, Penzberg, Germany), following the manufacturer’s 132 
instructions. This is a colorimetric assay for the quantification of cell viability and proliferation, 133 
based on the cleavage of the tetrazolium salt WST-1 by mitochondrial dehydrogenases of viable 134 
cells. Briefly, 10 μl of WST-1 were added to each well. After 1-h incubation, absorbance at 450 nm 135 
was measured using a plate reader (Model 680 Microplate Reader; Bio-Rad, Laboratories S.r.l., 136 
Milan, Italy). Four replicate wells were used to determine each data point. 137 
Cell Morphology  138 
After 72 hours of treatment, cell morphology was observed under Diavert inverted light microscope 139 
(Leitz, Wetzlar, Germany); photos were taken at x200 magnifications by Leica DC100 digital 140 
camera system (Microsystems,Wetzlar, Germany) using Leica Qwin as software for image 141 
processing. 142 
Gene expression 143 
At defined times after treatment, total RNA was extracted from hASCs and primary tenocytes using 144 
TRIzol Reagent (Invitrogen Ltd, Paisley, UK). DNase I was added to remove remaining genomic 145 
DNA. 1 μg sample of total RNA was reverse-transcribed with iScript cDNA Synthesis Kit (Bio-Rad 146 
Laboratories S.r.l., Milan, Italy) following manufacturer’s protocol. Primers (Table S1) were 147 
designed using Beacon Designer 5.0 software according to parameters outlined in the Bio-Rad 148 
iCycler Manual. The specificity of primers was confirmed by BLAST analysis. Real-time 149 
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polymerase chain reaction was performed using a BioRad iQ iCycler Detection System (Bio-Rad 150 
Laboratories S.r.l., Milan, Italy) with SYBR green fluorophore. Reactions were performed in a total 151 
volume of 25 μl containing 12.5 μl IQ SYBR Green Supermix (Bio-Rad Laboratories S.r.l., Milan, 152 
Italy), 1 μl of each primer at 10 μM concentration, and 5 μl of the previously reverse-transcribed 153 
cDNA template. The protocol used is as follows: denaturation (95°C for 5 min), amplification 154 
repeated 40 times (95°C for 15 s, 60°C for 30 s). A melting curve analysis was performed following 155 
every run to ensure a single amplified product for every reaction. All reactions were carried out at 156 
least in triplicate for each sample. Results were normalized using the geometric mean for three 157 
different housekeeping genes (β-actin and ribosomal protein L13A and RPLPO) and expressed as 158 
relative expression fold vs untreated controls (Basal). 159 
Immunofluorescence microscopy 160 
After different treatments, cells (2×10
3
) were seeded in 96-well plates (Corning, New York, NY, 161 
USA). After 1 and 4 weeks, cells were fixed in acetone/methanol (1:1) at 4°C for 20 minutes, 162 
permeabilized with PBS containing 0.5% Triton X-100, 0.05% NaN3 and incubated with the 163 
following antibodies: polyclonal sheep anti-type I collagen (COL1, 2 g/ml, R&D Systems, 164 
Minneapolis, MN, USA) and polyclonal rabbit anti-fibronectin 1 (FN1, 1:500, Sigma–Aldrich, 165 
Saint Louis, MO, USA), at 4°C overnight. Detection with secondary antibodies was as follows: for 166 
COL1, anti-sheep conjugated with Alexa Fluor 594 (1:500, Invitrogen, San Diego, CA, USA) and 167 
for FN1, anti-rabbit conjugated with cy3 (1:1000, GE Healthcare Europe, Milan, Italy). Nuclear 168 
staining was obtained by Hoechst 33258 [500 ng/ml in dimethylsulphoxide (DMSO)] in PBS. Cells 169 
were washed twice with distilled water. Cells were observed by inverted microscope Leica DMI 170 
4000 B (Leica Microsystems, Wetzlar, Germany) and photos of single channels and overlayers at 171 
x200 magnifications, were taken by Leica DCF340 FX digital camera system (Leica Microsystems, 172 
Wetzlar, Germany). Fluorescence was quantified using ImageJ (version 1.48, NIH, Bethesda, 173 
Maryland) imaging software.  174 
 175 
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Immunoblotting 176 
At different times after treatments, cell culture media were recovered and both hASC cells and 177 
tenocytes were scraped from the flask in the presence of 1 mL lysis buffer (50 mM Tris–HCl pH 178 
7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% sodium deoxycholate, 1% Nonidet P-40, 179 
0.1% SDS, 10 mg/mL PMSF, 30 L/mL aprotinin, and 100 mM sodium orthovanadate). Cell lysates 180 
were incubated in ice for 30–60 minutes. At completion, tubes were centrifuged at 4 °C for 20 181 
minutes at 15,000 x g. Media and cell lysates were separated on SDS-PAGE, transferred to PVDF 182 
and probed with the following antibodies: polyclonal anti-COL1 (1:800, R&D Systems, 183 
Minneapolis, MN), for culture media; polyclonal anti-FN1 (1:10000, Sigma–Aldrich, Saint Louis, 184 
MO, USA), for cell lysates. The membrane for FN1 was then stripped and reprobed with a mouse 185 
monoclonal anti-Tubulin antibody (1:10,000, Sigma–Aldrich, Saint Louis, MO, USA) to check 186 
protein loading. Red ponceau was used to confirm equal loading for type I collagen membrane. 187 
Proteins were detected with Pierce Super Signal chemiluminescent substrate. Bands were 188 
photographed and analyzed using Kodak 1D Image Analysis software.  189 
Masson Trichrome staining  190 
After different treatments, cells (25x10
4
) were seeded on sterilized coverslips (22 x 22 mm) placed 191 
in 6 cm Petri dishes and kept in a humidified incubator with 5% CO2 at 37°C.  192 
After 4 weeks, the cells grown on coverslips were fixed in 4% neutral-buffered formalin for 10 min 193 
and dehydrated through a series of alcohols up to absolute alcohol. The slides were first stained in 194 
modified Harris’s haematoxylin for 5 min; then, rinsed in lithium carbonate solution until the 195 
sections changed colour to blue. Subsequently, the slides were washed and stained in scarlet-acid 196 
fuchsine solution for 7-10 min. The slides were rinsed in a 1% acetic acid solution and immersed in 197 
phosphomolybdic acid for 4-5 min. The sections were transferred to Light Green and stained for 7-198 
10 min. After that, they were placed in 1% acetic acid solution. The slides were then dehydrated 199 
through 95% ethyl alcohol, absolute ethyl alcohol and cleared in xylene before being mounted. 200 
Slides were observed by microscope Leica DM2000 (Leica Microsystems, Wetzlar, Germany) and 201 
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photos were taken by Leica ICC50 HD digital camera system (Leica Microsystems, Wetzlar, 202 
Germany) at x200 final magnification. ImageJ (version 1.48, NIH, Bethesda, Maryland) imaging 203 
software was used to analyze Masson trichrome digital images and quantify the amount of collagen.  204 
Alizarin Red staining 205 
Calcium deposition was evaluated at 4 weeks by staining with 40 mM Alizarin Red-S (ARS, pH 206 
4.1). After fixation in ethanol and washing with Tris-buffered saline, cells were stained with ARS 207 
for 15 min, washed with Tris-buffered saline and observed under light microscopy. Cells were 208 
observed under inverted microscope Leica DMI 3000 B (Leica Microsystems, Wetzlar, Germany) 209 
and photographed by Leica DCF310 FX digital camera system (Leica Microsystems, Wetzlar, 210 
Germany) at x400 final magnification. 211 
Statistical analysis 212 
Data are expressed throughout the text as means ± SD. The means were calculated from n=5 for 213 
hASCs, and n=2 for primary tenocytes, respectively. 3 technical replicates were used for each 214 
donor. Comparison between groups was performed with analysis of variance (two-way ANOVA) 215 
and the threshold of significance was calculated with the Bonferroni test. Statistical significance 216 
was set at p<0.05. 217 
218 
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Results 219 
hASC characterization  220 
More than 95% of hASCs expressed CD13, CD44 and CD105, whereas a very low expression of 221 
CD14 (1%) and no expression of CD34 and CD45 was detected (Table S2). Moreover, a positivity 222 
of at least 95% for the same markers was also maintained in subsequent steps (data not shown). As 223 
we reported elsewhere (14,15), hASCs were able to differentiate into osteogenic and adipogenic 224 
lineages under specific culture conditions, confirming their differentiating potential. 225 
ESW effect on cell viability and morphology 226 
The energy level and number of shots used for ESW treatment (EFD =0.32 mJ/mm
2
; peak positive 227 
pressure 90 MPa, 1000 shots) allowed a viability > 80% soon after treatment (Table S2) and did not 228 
modify cell growth up to 9 days (Figure 1, panel A). 229 
Light microscopy was used to evaluate the differences in cell morphology in response to treatments 230 
(Figure 1, panel B). After 72 hours, cells in basal conditions exhibited a polygonal phenotype; on 231 
the contrary, combined treatment with tenogenic medium and ESW determined the appearance of 232 
an elongated and spindle shaped fibroblastic morphology. 233 
Effects on tenogenic gene expression 234 
As shown in Figure 2 (panels A and B), after 48 hours’ treatment, tenogenic medium alone 235 
significantly increased the expression of the two transcription factor scleraxis (SCX) (panel A, 236 
TENO vs Basal: 3.5 times, p<0.001) and eyes absent 2 (EYA2) (panel B, TENO vs Basal: 2.5 times, 237 
p<0.001); but, the greatest effect was obtained by using the combined treatment with tenogenic 238 
medium and ESW (for SCX, panel A: TENO ESW vs Basal: 5.8 times, p<0.001; TENO ESW vs 239 
TENO: 1.8 times, p<0.001; for EYA2, panel B: TENO ESW vs Basal: 3.0 times, p<0.001; TENO 240 
ESW vs TENO: 1.2 times, p<0.001).  241 
As both SCX and EYA2 regulate the expression of the tendon extracellular matrix proteins (16,17), 242 
we evaluated the expression of fibronectin (FN1), type I collagen (COL1) and tenomodulin (TNMD) 243 
at 7 days after treatment. Tenogenic medium significantly increased the expression of FN1 (Figure 244 
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2, panel C, TENO vs Basal: 2.7 times, p<0.001), COL1 (Figure 2, panel D, TENO vs Basal: 1.22 245 
times, p<0.05), and TNMD (Figure 2, panel E, TENO vs Basal: 2.9 times, p<0.01); again the 246 
combined treatment determined the best effect (for FN1, panel C: TENO ESW vs Basal: 4.25 times, 247 
p<0.001; TENO ESW vs TENO: 1.6 times, p<0.001; for COL1, panel D: TENO ESW vs Basal: 248 
1.36 times, p<0.01; TENO ESW vs TENO: 1.1 times, p<0.05; for TNMD, panel E: TENO ESW vs 249 
TENO: 4.5 times, p<0.001). Moreover, as far as tenomodulin expression is concerned, ESW 250 
treatment alone significantly increased its expression (panel E: ESW vs Basal: 2.5 times, p<0.05). 251 
Notably, after the combined treatment, levels of expression of both transcription factors as well as 252 
of the extracellular matrix proteins were comparable and even greater than those observed in 253 
primary culture of tenocytes, used as positive controls. 254 
Effects on extracellular matrix protein deposition 255 
The effect on the extracellular matrix proteins FN1 and COL1 was further confirmed by the 256 
evaluation of protein deposition. 257 
Effects on FN1 258 
After 7-day-treatments, tenogenic medium significantly increased FN1 production, as demonstrated 259 
by both immunofluorescence (Figure 3, panel A, TENO vs Basal, p<0.01) and western blotting 260 
(Figure 3, panels B and C, TENO vs Basal, p<0.05); but was the combination of tenogenic medium 261 
and ESW that gave the best result in terms of FN1 induction (immunofluorescence, Figure 3, panel 262 
A, TENO ESW vs Basal, p<0.001; TENO ESW vs TENO, p<0.05; western blotting, Figure 3, 263 
panels B and C, TENO ESW vs Basal, p<0.001; TENO ESW vs TENO, p<0.01).  264 
Effects on COL1 265 
The same behavior was also observed for COL1 production. In fact, after 7 days, already tenogenic 266 
medium alone significantly increased COL1 (immunofluorescence, Figure 4, panel A, TENO vs 267 
Basal, p<0.001; western blotting, Figure 4, panels B and C, TENO vs Basal, p<0.001); again, was 268 
the combination of tenogenic medium and ESW that gave the best results in terms of COL1 269 
production (immunofluorescence, Figure 4, panel A, TENO ESW vs Basal, p<0.001; TENO ESW 270 
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vs TENO, p<0.05; western blotting, Figure 4, panels B and C, TENO ESW vs Basal, p<0.001; 271 
TENO ESW vs TENO, p<0.01). 272 
In addition, the increased COL1 production was maintained up to five weeks, as demonstrated by  273 
immunofluorescence (Figure 5, panels A and B: TENO vs Basal p<0.01; TENO ESW vs Basal 274 
p<0.001; TENO ESW vs TENO p<0.001). Interestingly, at this time point the combined treatment 275 
(Figure 5, panel A) determined the formation of parallel collagen fibers, which play an important 276 
role in regulating tenoblast function and differentiation (18). Finally, the appearance of collagen 277 
fibers (arrows) was confirmed by Masson trichrome staining, as shown in Figure 5, panels C and D 278 
(TENO vs Basal p<0.01; TENO ESW vs Basal p<0.001; TENO ESW vs TENO p<0.001).    279 
Effects on integrin expression 280 
To get insights into the mechanisms involved in the effect of ESW in tenogenic differentiation, the 281 
expression of integrins involved in mechanotransduction was assessed. We evaluated the expression 282 
of integrins 1, 2, 5, 6, 10, 11 and V and of integrins and the most expressed in tendons 283 
and ligaments (19). Among these, after 72 hours, the expression of G , 6 ( G  and 1 284 
( G 1) integrins, was affected by our experimental treatments, as shown in Figure 6. The 285 
expression of G Figure 6, panel A) was significantly increased by ESW alone (ESW vs Basal: 286 
4.7 times, p<0.001), by tenogenic medium (TENO vs Basal: 2.1 times, p<0.05) and by the 287 
combined treatment (TENO ESW vs Basal: 8 times, p<0.001) respectively. The latter was the most 288 
effective (TENO ESW vs ESW: 1.7 times, p<0.001; TENO ESW vs TENO: 3.8 times, p<0.001). 289 
The expression of G Figure 6, panel B) was significantly increased by ESW alone (ESW vs 290 
Basal: 4.7 times, p<0.001), by tenogenic medium (TENO vs Basal: 1.9 times, p<0.01) and by the 291 
combined treatment (TENO ESW vs Basal: 5.9 times, p<0.001) respectively. The latter was the 292 
most effective (TENO ESW vs ESW: 1.3 times, p<0.01; TENO ESW vs TENO: 3.1 times, p<0.01).  293 
The expression of G 1 Figure 6, panel C) was significantly increased by ESW alone (ESW vs 294 
Basal: 1.7 times, p<0.01) and by the combined treatment (TENO ESW vs Basal: 2.3 times, 295 
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p<0.001). The latter was again the most effective (TENO ESW vs ESW: 1.4 times, p<0.05; TENO 296 
ESW vs TENO: 2.1 times, p<0.001).  297 
Effects on osteogenic differentiation 298 
As we reported (14) that ESW treatment, especially when combined with specific osteogenic 299 
medium, elicited the differentiation of hASCs towards osteoblast-like cells, we assessed whether the 300 
combined treatment could lead to the osteogenic differentiation of hASCs. As reported in Figure 7, 301 
the combined treatment with tenogenic medium and ESW had no effect on bone morphogenetic 302 
protein-2, BMP-2 (panel A), runt-related transcription factor 2, Runx2 (panel B) and alkaline 303 
phosphatase, ALP (panel C) expression and determined no production of calcium deposits (panel 304 
D). Moreover, present data confirm our previous results (14) about the positive effect of ESW 305 
treatment alone on the expression of BMP-2, Runx2 and ALP and on calcium deposits.  306 
307 
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Discussion 308 
The present study demonstrates that ESW potentiate the effects of tenogenic medium on the 309 
differentiation of hASCs towards tenoblast-like cells, as evidenced by the up-regulation of specific 310 
gene markers, spindle-shaped cell morphology and extracellular matrix fiber deposition. These 311 
findings support the potency of combining stem cells, mechanical forces and biochemical factors to 312 
induce and sustain tendon differentiation and regeneration. 313 
Since their first description by Zuk et al.
 
(4), it is well known that ASCs are at least as efficient as 314 
bone marrow-derived stem cells when used in tissue engineering; moreover, the low donor site 315 
morbidity and high rate of growth during culturing, make them an ideal cell type to be used in 316 
regenerative medicine. ASCs have been successfully used in in vivo models of tendon repair (20) 317 
and some Authors reported that ASCs work better than bone marrow stem cells in in vivo tendon 318 
injury models (21). Moreover, it has been described that ASC source can be biochemically induced 319 
towards tenogenic commitment, validating its potential for tendon regeneration strategies (22). 320 
Accordingly, in our in vitro model, tenogenic medium increased the expression of specific tendon 321 
genes and determined collagen and fibronectin deposition.  322 
Here we demonstrate that mechanical stimulation with ESW enhances the biochemical effects of a 323 
containing-growth factor specific medium to drive hASCs towards a tenoblast-like phenotype. Our 324 
results are in line with previous reports about the role of mechanical forces in tendon healing and 325 
stem cell differentiation towards tenoblasts. Pulsed electromagnetic fields influence the 326 
proliferation, tendon-specific marker expression and release of anti-inflammatory cytokines and 327 
angiogenic factors of healthy human tendon cells (23). Cyclic tension promotes fibroblastic 328 
differentiation of stem cells seeded on fibrous collagen-based scaffolds (24) and stem cell 329 
differentiation toward tenocytes (25, 26). Moreover, the combination of the tendon transcription 330 
factor scleraxis and mechanical stress synergistically drives differentiation of human embryonic 331 
stem cells to induce teno-lineage commitment (27).  332 
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As far as the biological effects of ESW therapy on tendon healing are concerned, several 333 
experimental studies on animal models have been performed (28-34), suggesting a role of ESW in 334 
determining the activation of a complex network of molecules acting on collagen synthesis and 335 
angiogenesis. On the contrary, to date only two studies from the same group described the effects of 336 
ESW in vitro on human healthy and ruptured tendon-derived tenocytes (35, 36) and another study 337 
demonstrated that soft-focused ESW treatment was able to induce positive modulation of cell 338 
viability, proliferation and tendon-specific marker expression, as well as release of anti-339 
inflammatory cytokines (37). However, to date no other study investigated the possibility of ESW 340 
to facilitate the differentiation of human mesenchymal stem cells towards tenocytes. 341 
As far as gene expression is concerned, a panel of genes typically expressed by tendons was 342 
increased by the combined treatment. We observed an enhanced expression of the transcription 343 
factor scleraxis, which is the only direct molecular regulator of tenocyte differentiation identified 344 
and expressed in tendon progenitors (38). Moreover, the combined treatment with tenogenic 345 
medium and ESW induced the expression of the tendon extracellular matrix proteins fibronectin 346 
and type I collagen. Type I collagen is the most abundant protein in healthy tendon tissue (39). 347 
Notably, the combined treatment antagonized the ESW-induced BMP-2 expression, which is known 348 
to stimulate osteogenesis in both hASCs (18) and in tendon-derived stem cells (40).  As a 349 
consequence, no increase of Runx2 and ALP and no production of calcium deposits were observed. 350 
Nevertheless, being the present an in vitro study, only future work in animal models will 351 
definitively exclude any potential effect of the combined treatment on ectopic calcification of 352 
tendons. 353 
Integrins mediate cell–matrix interactions and are the transducers of the mechanochemical 354 
information between extracellular and intracellular compartments (41). Present work suggests an 355 
involvement of integrins as possible mediators of ESW effects at cellular and molecular levels. In 356 
fact, ESW increased the expression of 2, 1 and α6 subunits. 2/ 1 integrin is a receptor for 357 
laminin, collagen, and fibronectin (19). It is responsible for cell adhesion to collagens, modulation 358 
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of collagen and collagenase gene expression, force generation and organization of newly 359 
synthesized extracellular matrix (42). The α6 subunit, expressed in vascular structures in the healing 360 
ligaments (43) and in the healing tendons (44), is involved in vasculogenesis. 361 
In conclusion, the novelty of the present work is the ability of ESW to boost the process of hASC 362 
differentiation towards tenoblast-like cells induced by tenogenic medium, supporting a role for 363 
ESW as a new tool to be used in combination with ASC in tendon tissue engineering.  364 
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Figure Legends 505 
Figure 1. Effects on cell viability (panel A). Basal, ESW, TENO and TENO ESW-treated h ASC 506 
cells were cultured up to 9 days.  At 1, 3, 5, 7 and 9 days, cell viability was determined by the 507 
WST-1 method, and expressed as ratio vs day 0. Effects on cell morphology (panel B). 508 
Morphology of Basal, ESW, TENO and TENO ESW-treated hASC cells. Magnification x200.  509 
Figure 2. Effects on tendon-specific gene expression. mRNA expression of SCX (panel A), 510 
EYA2 (panel B), FN1 (panel C), COL1 (panel D) and TNMD (panel E) was evaluated by RT-PCR. 511 
Results are normalized for three different housekeeping genes (β-actin, RPLPO and L13A) and 512 
expressed as relative expression fold vs Basal. Significance vs Basal: *, p<0.05; ***, p<0.001. 513 
Significance TENO ESW vs TENO: °, p<0.05; °°°, p<0.001. 514 
Figure 3. Effects on fibronectin. Immunofluorescence for FN1 (panel A) in Basal, ESW, TENO 515 
and TENO ESW-treated hASC cells after 7 days. Magnification x200. FN1 fluorescence 516 
quantification. Significance vs Basal: ***, p<0.001. Significance TENO ESW vs TENO: °, p<0.05. 517 
Immunoblotting for fibronectin (panel B) in Basal, ESW, TENO and TENO ESW-treated hASC 518 
cells. Anti-Tubulin antibody was used to confirm equal loading. Blot is representative of five 519 
independent experiments. Semiquantitative analysis of immunoblotting results (panel C). 520 
Significance vs Basal: *, p<0.05; ***, p<0.001. Significance TENO ESW vs TENO: °°, p<0.01. 521 
Tenocytes were used as positive controls. 522 
Figure 4. Effects on type I collagen after 7 days. Immunofluorescence for COL1 (panel A) in 523 
Basal, ESW, TENO and TENO ESW-treated h ASC cells. Magnification x200. COL1 fluorescence 524 
quantification. Significance vs Basal: ***, p<0.001. Significance TENO ESW vs TENO: °, p<0.05. 525 
Immunoblotting for COL1 (panel B) in cultured media from Basal, ESW, TENO and TENO ESW-526 
treated hASC cells. Red Ponceau was used to confirm equal loading. Blot is representative of five 527 
independent experiments. Semiquantitative analysis of immunoblotting results (panel C). 528 
Significance vs Basal: ***, p<0.001. Significance TENO ESW vs TENO: °°, p<0.01. Tenocytes 529 
were used as positive controls. 530 
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Figure 5. Effects on type I collagen after 5 weeks. Immunofluorescence for COL1 (panel A) in 531 
Basal, ESW, TENO and TENO ESW-treated hASC cells. Magnification x200. COL1 fluorescence 532 
quantification (panel B). Significance vs Basal: **, p<0.01 ***, p<0.001. Significance vs TENO: 533 
°°°, p<0.001. Masson trichrome staining (panel C) of Basal, ESW, TENO and TENO ESW-treated 534 
hASC cells. Collagen fibers are indicated by arrows. Magnification x200. Masson trichrome 535 
quantification (panel D). Significance vs Basal: **, p<0.01 ***, p<0.001. Significance TENO ESW 536 
vs TENO: °°°, p<0.001. 537 
Figure 6. Effects on integrin gene expression. mRNA expression of ITG 2 (panel A), ITG 6 538 
(panel B), ITG 1 (panel C) was evaluated by RT-PCR. Results are normalized for three different 539 
housekeeping genes (β-actin, RPLPO and L13A) and expressed as relative expression fold vs Basal. 540 
Significance vs Basal: *, p<0.05; **, p<0.01; ***, p<0.001. Significance vs ESW: 
#
, p<0.05; 
##
, 541 
p<0.01; 
###
, p<0.001. Significance TENO ESW vs TENO: °°, p<0.01; °°°, p<0.001. 542 
Figure 7. Effects on BMP-2 (panel A), Runx2 (panel B) and ALP (panel C) gene expression. 543 
mRNA expression was evaluated by RT-PCR. Results are normalized for three different 544 
housekeeping genes (β-actin, RPLPO and L13A) and expressed as relative expression fold vs Basal. 545 
Significance vs Basal: **, p<0.01; ***, p<0.001. Significance TENO ESW vs TENO: °, p<0.05. 546 
Effect on calcium deposition (panel D): Calcium deposits at 4 weeks (arrows) as revealed by 547 
Alizarin Red Staining. Magnification x400. Staining is representative of five independent 548 
experiments. 549 
550 
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Table S1 Primers for real-time PCR 558 
 559 
 560 
 561 
Gene Primer sequence 
 
NCBI Reference 
SCX 
Sense: 5’-GAA CAC CCA GCC CAA ACA GATC-3’ 
Antisense: 5’-GCG GTC CTT GCT CAA CTT TCT C-3’ 
NM_001080514.2 
EYA2 
Sense: 5’-GAT TGA GCG TGT GTT CGT GTG G-3’ 
Antisense: 5’-GTG GTG TCC TTC CCG TAT CTG G-3’ 
NM_005244.4 
FN1 
Sense: 5’-CCG TGG CAT TGG GGA GTG G-3’ 
Antisense: 5’-GGG TGG GAG TTG GGC TGA C-3’ 
NM_212482.2 
COL1 
Sense: 5’-ATG GAT GAG GAG ACT GGC AAC C-3’ 
Antisense: 5’-GGA AGG GCA GGC GTG ATG G-3’ 
NM_000089.3 
TNMD 
Sense: 5’-ACGGATACACTGGCATCTACTTCG-3’ 
Antisense: 5’-GGGACCCAAATCACTGACTGTTC-3’ 
NM_022144 
29 
 
G  
Sense: 5’-ACA TGG GAA CAG AGA AGG AGG AG-3’ 
Antisense: 5’-TGA ATT GTG CTG CCG AGA TGA AC-3’ 
NM_181501.1 
G
Sense: 5’-TGT AGC AAC ATC CCA GAC ATC CC-3’ 
Antisense: 5’-GCA CTT CGT CGC CCA CCA G-3’ 
NM_002203.3 
G  
Sense: 5’-CGG GCT CCT TCT TCG GAT TCT C -3’ 
Antisense: 5’-CAC TCC TGG CTG GCT GGT ATT AG -3’ 
NM_002205.4 
G
Sense: 5’-TCC TAC CCT GAT GTT GCT GTT GG-3’ 
Antisense: 5’-TCT GGC GGA GGT CAA TTC TGT TAG-3’ 
NM_001079818.2 
G  
Sense: 5’-GGG AAC CGA AGA GGG CAG TG -3’ 
Antisense: 5’-ACA GGC AGA AGA CAA GGA GAG C -3’ 
NM_003637.4 
G  
Sense: 5’-GCA GGC AGT GAC AGT AAT GAG C -3’ 
Antisense: 5’-CGT ATT TGA GGT GGA AGC GTA AGG -3’ 
NM_001004439.1 
G V 
Sense: 5’-TAG CGT ATC TGC GGG ATG AAT CTG -3’ 
Antisense: 5’-GGC GTG AAC TGG TTA AGA ATG GG -3’ 
NM_002210.4 
 
G 1 
Sense: 5’-TGC CTT GGT GTC TGT GCT GAG-3’ 
Antisense: 5’-CAA CAG TCG TCA ACA TCC TTC TCC-3’ 
NM_002211.3 
G 3 
Sense: 5’-CTT CAA TGC CAC CTG CCT CAA C -3’ 
Antisense: 5’-GGA CAG CCT CGC ACC TTG G -3’ 
NM_000212.2 
G 5 
Sense: 5’-TGC CTG CTG CTC CAC TCT G -3’ 
Antisense: 5’-AGC CTC CTG GTC ATC TTT CAC G -3’ 
NM_002213.4 
G 8 
Sense: 5’-GTG TGT GGA AGG TGT GAG TGC -3’ 
Antisense: 5’-TGA GAC AAA TTG TGA GGG TGA AGG -3’ 
NM_002214.2 
BMP-2 
Sense: 5’-CGG GAG AAG GAG GAG GCA AAG -3’ 
Antisense: 5’-GAA GCA GCA ACG CTA GAA GAC AG -3’ 
NM_001200.3 
Runx2 
Sense: 5’-CGG AGT GGA CGA GGC AAG AG-3’ 
Antisense: 5’-AGG CGG TCA GAG AAC AAA CTA GG -3’ 
NM_001024630.3 
30 
 
ALP
Sense: 5’-ATG AGG CGG TGG AGA TGG AC -3’ 
Antisense: 5’-CAT ACA GGA TGG CAG TGA AGG G -3’ 
NM_000478.5 
-ACT 
Sense: 5’-GCG AGA AGA TGA CCC AGA TC- 3’ 
Antisense: 5’- GGA TAG CAC AGC CTG GAT AG-3’ 
NM_001101.3 
L13A 
Sense: 5’-GCA AGC GGA TGA ACA CCA ACC-3’ 
Antisense: 5’-TTG AGG GCA GCA GGA ACC AC-3’ 
NM_012423.3 
RPLPO 
Sense: 5’-CGA CAA TGG CAG CAT CTA CAA CC-3’ 
Antisense: 5’-CAC CCT CCA GGA AGC GAG AAT G-3’ 
NM_001002.3 
 562 
 563 
 564 
 565 
 566 
Table S2. Mesenchymal stem cell marker expression  567 
 568 
 569 
CD 13 98.2 % ± 3.5 
CD 14 1.3% ± 0.4  
CD 34 NEG 
CD 44 99.3 % ± 0.6 
CD 45 NEG 
CD 90 96.9 % ± 0.1 
CD 105 96.8 % ± 2.6 
 570 
Table S3 Cell viability 571 
 572 
 573 
 574 
 575 
 576 
Treatment Viable cells 
Basal 98.3% 
ESW 83% 
TENO 97.6% 
TENO ESW 82.1% 
